Following $2.1B in recovered reimbursement in 2024, Iodine strengthens its leadership to meet growing demand for AI solutions that drive proven financial impact.
Iodine Software, the leading AI-powered revenue cycle company, announced the appointment of Valerie Mondelli, RPh, MBA, as Chief Commercial Officer. Mondelli joins the company’s executive leadership team at a pivotal time, as Iodine prepares to scale its impact following a landmark year in which it helped health systems recover more than $2.1 billion in reimbursement in 2024.
Health Technology Insights: eClinicalWorks and healow Genie Enhance Patient Communication in Tampa Bay
With more health systems under increasing financial strain and AI adoption on the rise, Iodine is one of the few healthcare AI companies delivering clear, quantifiable results. A recent McKinsey report noted that only 23% of healthcare executives said their AI vendors demonstrated positive ROI. In contrast, Iodine partners routinely recover millions in right-sized reimbursement, reduce denials, and streamline revenue cycle operations.
“As the healthcare market becomes more crowded with AI vendors, health systems need partners who don’t just promise impact—but prove it,” said William Chan, CEO and Co-Founder of Iodine Software. “Valerie brings decades of commercial leadership and a deep understanding of healthcare’s financial pressures. Her experience and customer-first mindset will help us align our teams and scale our growth strategy for even greater impact.”
Health Technology Insights: Bethany Children’s Partners with Cohesity to Enhance Data Security
Mondelli brings more than 25 years of commercial leadership experience across healthcare, retail pharmacy, payers, pharmaceutical manufacturers, and health IT. Most recently, she served as Chief Commercial Officer at RevSpring, where she led its transformation into a digital engagement and payments platform. Her experience spans companies like Eli Lilly, RelayHealth (McKesson), and FiServ, and in 2023, she was named one of Drug Store News’ Top Women in Business.
“Hospitals are under immense pressure—grappling with rising denials, financial strain, and mounting complexity,” said Valerie Mondelli, Chief Commercial Officer of Iodine Software. “What sets Iodine apart is its ability to turn deep clinical intelligence into financial impact. By helping health systems recover earned revenue and prevent denials, we’re not just improving margins—we’re reinforcing their ability to deliver on their care mission. I’m proud to join a team so committed to solving healthcare’s hardest problems.”
Hundreds of hospitals and health systems trust CognitiveML—Iodine’s proprietary Clinical Intelligence AI engine—purpose-built for healthcare’s complexity. By mirroring clinical judgment and leveraging one of the nation’s largest inpatient datasets, CognitiveML delivers the most complete picture of patient care. It uncovers hidden revenue by ensuring accurate documentation and coding—driving measurable financial and improved quality outcomes:
- 63% reduction in medical review time (from 15 to 5 minutes)
- $15M annualized impact through accurate level-of-care adjustments
- 139% increase in incremental financial return per facility, averaging $1.5M
Health Technology Insights: Octagos Launches OctaLink for AI-Driven Mobile Cardiac Monitoring
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
Source – businesswire
